{
  "relevance_rule": {},
  "priority_rules": [
    {
      "priority": "High",
      "rule_text": "BCL-2 + (CLL or FL or MZL or WM) + MCL",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "BCL-2",
          "CLL",
          "FL",
          "MZL",
          "WM",
          "MCL"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Direct keyword matching for all terms; all are client keywords."
    },
    {
      "priority": "High",
      "rule_text": "Acalabrutinib",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Acalabrutinib"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Single drug name, present in client keywords."
    },
    {
      "priority": "High",
      "rule_text": "zanubrutinib",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "zanubrutinib"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Single drug name, present in client keywords."
    },
    {
      "priority": "High",
      "rule_text": "pirtobrutinib",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "pirtobrutinib"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Single drug name, present in client keywords."
    },
    {
      "priority": "High",
      "rule_text": "venetoclax",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "venetoclax"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Single drug name, present in client keywords."
    },
    {
      "priority": "High",
      "rule_text": "BTK",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "BTK"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Single target, present in client keywords."
    },
    {
      "priority": "High",
      "rule_text": "CAR-T + (CLL)",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "CAR-T",
          "CLL"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Both terms are client keywords."
    },
    {
      "priority": "High",
      "rule_text": "Bispecific Antibody (CLL)",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Bispecific Antibody",
          "CLL"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Both terms are client keywords."
    },
    {
      "priority": "High",
      "rule_text": "brexucabtagene autoleucel",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "brexucabtagene autoleucel"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Single drug name, present in client keywords."
    },
    {
      "priority": "High",
      "rule_text": "Lisocabtagene maraleucel",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Lisocabtagene maraleucel"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Single drug name, present in client keywords."
    },
    {
      "priority": "High",
      "rule_text": "Sonrotoclax",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Sonrotoclax"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Single drug name, present in client keywords."
    },
    {
      "priority": "High",
      "rule_text": "BGB-11417",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "BGB-11417",
          "BGB11417"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Drug name, present in client keywords."
    },
    {
      "priority": "High",
      "rule_text": "CRISTALLO",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "CRISTALLO"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Study name, present in client keywords."
    },
    {
      "priority": "High",
      "rule_text": "MAJIC",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "MAJIC"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Study name, present in client keywords."
    },
    {
      "priority": "High",
      "rule_text": "CLL-16",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "CLL-16",
          "CLL16"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Study name, present in client keywords."
    },
    {
      "priority": "High",
      "rule_text": "CLL",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "CLL"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Disease name, present in client keywords."
    },
    {
      "priority": "Medium",
      "rule_text": "mutant (m)BCL-2 +(CLL or NHL)",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "mutant (m)BCL-2",
          "CLL",
          "NHL",
          "mutant BCL-2",
          "mBCL-2"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [
        "FL",
        "MZL",
        "WM",
        "MCL"
      ],
      "reasoning": "Keyword matching; excludes higher priority rule subtypes."
    },
    {
      "priority": "Medium",
      "rule_text": "T-cell redirection + (CLL)",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "T-cell redirection",
          "CLL",
          "redirected T cell",
          "redirecting T cell"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [
        "CAR-T",
        "Bispecific Antibody"
      ],
      "reasoning": "Keyword matching; excludes higher priority CAR-T and Bispecific Antibody rules."
    },
    {
      "priority": "Medium",
      "rule_text": "Nemtabrutinib",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Nemtabrutinib"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Drug name, present in client keywords."
    },
    {
      "priority": "Medium",
      "rule_text": "Loncastuximab Tesirine",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Loncastuximab Tesirine"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Drug name, present in client keywords."
    },
    {
      "priority": "Medium",
      "rule_text": "BGB11417",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "BGB11417",
          "BGB-11417"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [
        "BGB-11417"
      ],
      "reasoning": "Medium priority for BGB11417 unless covered by high priority BGB-11417."
    },
    {
      "priority": "Medium",
      "rule_text": "Orelabrutinib",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Orelabrutinib"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Drug name, present in client keywords."
    },
    {
      "priority": "Medium",
      "rule_text": "BTK degrader (CLL)",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "BTK degrader",
          "CLL",
          "Bruton tyrosine kinase Degrader"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [
        "BTK"
      ],
      "reasoning": "Keyword matching; excludes higher priority BTK rule."
    },
    {
      "priority": "Medium",
      "rule_text": "NX-5948",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "NX-5948"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Drug name, present in client keywords."
    },
    {
      "priority": "Medium",
      "rule_text": "NX-2127",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "NX-2127"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Drug name, present in client keywords."
    },
    {
      "priority": "Medium",
      "rule_text": "Lisaftoclax",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Lisaftoclax"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Drug name, present in client keywords."
    },
    {
      "priority": "Medium",
      "rule_text": "Axatillimab",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Axatillimab"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Drug name, present in client keywords."
    },
    {
      "priority": "Low",
      "rule_text": "MRD + (CLL)",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "MRD",
          "CLL",
          "Measurable Residual Disease"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Keyword matching; lower priority for MRD studies."
    },
    {
      "priority": "Low",
      "rule_text": "zilovertamab vedotin",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "zilovertamab vedotin"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Drug name, present in client keywords."
    },
    {
      "priority": "Low",
      "rule_text": "zilovertamab",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "zilovertamab"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [
        "zilovertamab vedotin"
      ],
      "reasoning": "Drug name, present in client keywords; excludes higher priority zilovertamab vedotin."
    },
    {
      "priority": "Low",
      "rule_text": "epcoritamab (CLL)",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "epcoritamab",
          "CLL"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Drug name and disease, present in client keywords."
    },
    {
      "priority": "Low",
      "rule_text": "mosunetuzumab (CLL)",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "mosunetuzumab",
          "CLL"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Drug name and disease, present in client keywords."
    }
  ]
}